• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.

作者信息

Shimabukuro Tom

机构信息

CDC COVID-19 Response Team, Atlanta, Georgia, USA.

Food and Drug Administration, Washington, DC, USA.

出版信息

Am J Transplant. 2021 Mar;21(3):1326-1331. doi: 10.1111/ajt.16517.

DOI:10.1111/ajt.16517
PMID:33641268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013433/
Abstract
摘要

相似文献

1
Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.2020年12月21日至2021年1月10日美国接种第一剂莫德纳新冠疫苗后的过敏反应，包括过敏反应
Am J Transplant. 2021 Mar;21(3):1326-1331. doi: 10.1111/ajt.16517.
2
Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020.2020年12月14日至23日美国接种首剂辉瑞-生物科技公司新冠病毒疫苗后发生的过敏反应，包括过敏反应。
Am J Transplant. 2021 Mar;21(3):1332-1337. doi: 10.1111/ajt.16516.
3
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.美国 2020 年 12 月 21 日-2021 年 1 月 10 日期间，在接种 Moderna COVID-19 疫苗第一针后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1.
4
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
5
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
6
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.接种辉瑞-生物科技公司新冠疫苗第一剂后包括过敏反应在内的过敏反应。
JAMA. 2021 Feb 23;325(8):780-781. doi: 10.1001/jama.2021.0600.
7
Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.基于人群的急性发作 COVID-19 mRNA 疫苗接种相关过敏反应的发生率、严重程度及相关风险因素。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):827-836. doi: 10.1016/j.jaip.2021.12.021. Epub 2021 Dec 29.
8
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.新型mRNA新冠疫苗在重度过敏患者中的安全性
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
9
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.高过敏风险成年人接种辉瑞-BioNTech COVID-19 疫苗后的过敏反应发生率。
JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255.
10
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.使用两步分级方案管理与 COVID-19 疫苗相关的疑似过敏反应和第二剂接种。
Allergy Asthma Proc. 2021 Nov 1;42(6):515-521. doi: 10.2500/aap.2021.42.210075.

引用本文的文献

1
Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodies.在超免疫猪模型中，Comirnaty诱导的心肺窘迫及补体介导的类过敏反应的其他症状：抗聚乙二醇抗体的因果作用
Vaccine X. 2024 May 23;19:100497. doi: 10.1016/j.jvacx.2024.100497. eCollection 2024 Aug.
2
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.报告的 COVID-19 疫苗接种后主要严重不良事件的发生率和处理。
Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224.
3
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines.疫苗设计的最新进展：从活疫苗到重组毒素疫苗。
Toxins (Basel). 2023 Sep 8;15(9):563. doi: 10.3390/toxins15090563.
4
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
5
DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond.用于疫情防范的DNA疫苗：新冠病毒及其他。
Vaccines (Basel). 2023 May 23;11(6):1016. doi: 10.3390/vaccines11061016.
6
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG.抗聚乙二醇（PEG）抗体在含 PEG 的 COVID-19 疫苗过敏反应中的作用：PEG 具有免疫原性的证据。
Vaccine. 2023 Jul 12;41(31):4561-4570. doi: 10.1016/j.vaccine.2023.06.009. Epub 2023 Jun 5.
7
[Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].[新冠疫苗接种前进行过敏科会诊的原因及其结果：北莱茵-威斯特法伦州一家过敏中心的两年经验]
Dermatologie (Heidelb). 2023 Jul;74(7):511-519. doi: 10.1007/s00105-023-05152-3. Epub 2023 May 4.
8
Immediate Adverse Events Following COVID-19 Vaccination in Australian Pharmacies: A Retrospective Review.澳大利亚药店接种新冠疫苗后的即时不良事件：一项回顾性研究
Vaccines (Basel). 2022 Nov 29;10(12):2041. doi: 10.3390/vaccines10122041.
9
Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS.与BNT162b2、Ad26.COV2.S和mRNA-1273新冠疫苗相关的严重不良反应：通过疫苗不良事件报告系统（VAERS）深入了解
Front Pharmacol. 2022 Nov 7;13:921760. doi: 10.3389/fphar.2022.921760. eCollection 2022.
10
A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination.一项针对 COVID-19 疫苗接种后死亡的尸检方法的系统回顾和建议。
Forensic Sci Int. 2022 Nov;340:111469. doi: 10.1016/j.forsciint.2022.111469. Epub 2022 Sep 20.

本文引用的文献

1
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
2
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020.美国免疫实施咨询委员会对使用 Moderna COVID-19 疫苗的临时建议-2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Jan 1;69(5152):1653-1656. doi: 10.15585/mmwr.mm695152e1.
3
Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity - United States, January 26-October 3, 2020.与 COVID-19 相关的超额死亡人数，按年龄、种族和族裔划分 - 美国，2020 年 1 月 26 日至 10 月 3 日。
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527. doi: 10.15585/mmwr.mm6942e2.
4
Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016.1990-2016 年疫苗不良反应报告系统报告的接种后过敏反应。
J Allergy Clin Immunol. 2019 Apr;143(4):1465-1473. doi: 10.1016/j.jaci.2018.12.1003. Epub 2019 Jan 14.
5
Vaccine-associated hypersensitivity.疫苗相关过敏反应。
J Allergy Clin Immunol. 2018 Feb;141(2):463-472. doi: 10.1016/j.jaci.2017.12.971.
6
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).疫苗不良事件报告系统（VAERS）中的安全性监测。
Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22.
7
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.过敏反应：免疫接种安全性数据的病例定义及数据收集、分析与呈现指南
Vaccine. 2007 Aug 1;25(31):5675-84. doi: 10.1016/j.vaccine.2007.02.064. Epub 2007 Mar 12.
8
The reporting sensitivities of two passive surveillance systems for vaccine adverse events.两种疫苗不良事件被动监测系统的报告敏感性。
Am J Public Health. 1995 Dec;85(12):1706-9. doi: 10.2105/ajph.85.12.1706.